Viewing Study NCT00690560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-02-08 @ 1:12 PM
Study NCT ID: NCT00690560
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2008-06-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma
Sponsor: Centre Antoine Lacassagne
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None contiguous stage II adult diffuse large cell lymphoma View
None noncontiguous stage II adult diffuse large cell lymphoma View
None stage I adult diffuse large cell lymphoma View
None stage III adult diffuse large cell lymphoma View
None stage IV adult diffuse large cell lymphoma View